Skip to content
PubMed This is a summary of 110 peer-reviewed journal articles Updated
Cardiology

Myocardial Infarction (Heart Attack): A Patient Guide

At a Glance

A heart attack is confirmed by acute heart muscle injury, often shown by a rise or fall in the blood protein cardiac troponin, plus evidence that the heart lacked oxygen. Recovery depends on treating the cause, taking medicines as prescribed, cardiac rehabilitation, and monitoring pumping strength.

A heart attack, or myocardial infarction, occurs when your heart muscle is damaged because it cannot get the oxygen it needs to function. While many people imagine a heart attack as a sudden, dramatic event marked by crushing chest pain, the reality is often more complex. A diagnosis requires acute myocardial injury—typically confirmed when a blood test detects a rise and/or fall in a protein called cardiac troponin above the test’s normal limit—combined with clinical evidence of ischemia, meaning the heart was starved of oxygen [1]. This means that even if your symptoms were less typical, such as severe fatigue, jaw pain, or nausea, the damage to your heart is a documented biological event that requires a dedicated recovery plan [2].

Understanding the specific cause of your heart attack is the first step in your treatment. Some heart attacks are caused by a sudden blood clot in a major artery, requiring immediate procedures to open the vessel. Others (Type 2 MI) are triggered by a “mismatch” where the heart is stressed by another illness or condition, and treatment focuses heavily on correcting that underlying oxygen supply-demand problem [3]. In some cases, known as MINOCA, the arteries may appear mostly clear even though a heart attack has occurred, requiring advanced imaging like a cardiac MRI to find the underlying mechanism [4].

Once you leave the hospital, your recovery shifts from an emergency response to a long-term protective strategy. This phase is anchored by essential medications tailored to your condition that prevent new clots, lower your cholesterol, and help your heart muscle heal without excessive scarring [5]. Taking these medications exactly as prescribed—especially your “antiplatelet” drugs—is one of the most critical things you can do to prevent a second event or a dangerous clot in a new stent [6]. These drugs provide a safety net that allows your heart the time and environment it needs to recover its pumping power.

Ultimately, recovering from a heart attack is an active process that extends far beyond taking pills. It involves participating in cardiac rehabilitation, where specialized teams help you rebuild your physical strength and confidence through supervised exercise [7]. You will also work closely with your doctors to monitor your heart’s efficiency, often measured by your ejection fraction (LVEF), to ensure your heart is regaining its strength [8]. By combining medical therapy with these lifestyle supports, you can take control of your heart health and move forward with a clear path toward long-term wellness.


Important Note: This guide does not replace your individualized discharge instructions. Always call emergency services (911) for new, severe symptoms such as chest pressure, extreme shortness of breath, fainting, or major bleeding. Never change or stop your medications without speaking directly to your prescribing care team.

Common questions in this guide

How is a myocardial infarction diagnosed if my symptoms are not classic?
Doctors look for a rise or fall in cardiac troponin above the test’s normal limit, showing acute injury to the heart muscle. They also look for clinical evidence that the heart was deprived of oxygen. Severe fatigue, jaw pain, or nausea can occur even without crushing chest pain.
What is the difference between a Type 1 and Type 2 heart attack?
A Type 1 heart attack is usually caused by a sudden clot in a major heart artery. A Type 2 heart attack occurs when another illness or stressor creates a mismatch between oxygen supply and demand. Treatment for Type 2 focuses on correcting the underlying problem as well as caring for the heart.
Can I have a heart attack if my arteries appear clear?
Yes. This situation is called MINOCA and means that a heart attack has occurred even though the coronary arteries appear mostly clear. Additional testing, including cardiac MRI, may help clinicians identify the underlying mechanism.
Why are antiplatelet medicines important after a heart attack or stent?
Antiplatelet medicines reduce the chance that a dangerous clot will form, including in a new stent, and help lower the risk of another heart attack. Take them exactly as prescribed and do not stop or change them without speaking with the prescribing care team.
What does ejection fraction tell me after a heart attack?
Ejection fraction, or LVEF, estimates how efficiently the heart pumps blood. Your clinicians use it to monitor whether heart strength is improving and to help guide treatment.
What is cardiac rehabilitation, and when should I start?
Cardiac rehabilitation is a supervised program that uses exercise and support to rebuild strength and confidence after a heart attack. Your care team should tell you when it is safe and appropriate to begin based on your condition and discharge plan.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my tests, do I have a Type 1 heart attack from a blockage or a Type 2 heart attack from other stressors?
  2. 2.What is my current 'ejection fraction' (LVEF), and how does that number affect my treatment plan?
  3. 3.Which of my new medications is the most critical for preventing a clot in my stent?
  4. 4.When should I begin my first session of cardiac rehabilitation?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (8)
  1. 1

    High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification.

    Kozinski M, Krintus M, Kubica J, Sypniewska G

    Critical reviews in clinical laboratory sciences 2017; (54(3)):143-172 doi:10.1080/10408363.2017.1285268.

    PMID: 28457177
  2. 2

    Sex disparities in pre-hospital delay in patients with acute myocardial infarction: a systematic review and meta-analysis.

    Hu D, Duan Y, Song J, Wei L

    BMC cardiovascular disorders 2026; (26(1)).

    PMID: 42265637
  3. 3

    Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury.

    DeFilippis AP, Chapman AR, Mills NL, et al.

    Circulation 2019; (140(20)):1661-1678 doi:10.1161/CIRCULATIONAHA.119.040631.

    PMID: 31416350
  4. 4

    Myocardial infarction with non-obstructive coronary arteries: A comprehensive review and future research directions.

    Vidal-Perez R, Abou Jokh Casas C, Agra-Bermejo RM, et al.

    World journal of cardiology 2019; (11(12)):305-315 doi:10.4330/wjc.v11.i12.305.

    PMID: 31908730
  5. 5

    The Balancing Act: A Rational Approach to Postintervention Dual Antiplatelet Therapy.

    Mehta N, Samat D

    The Journal of the Association of Physicians of India 2024; (72(11)):11-13 doi:10.59556/japi.72.0668.

    PMID: 39563109
  6. 6

    Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.

    Yeh RW, Kereiakes DJ, Steg PG, et al.

    Journal of the American College of Cardiology 2015; (65(20)):2211-21.

    PMID: 25787199
  7. 7

    Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis.

    Dibben GO, Faulkner J, Oldridge N, et al.

    European heart journal 2023; (44(6)):452-469 doi:10.1093/eurheartj/ehac747.

    PMID: 36746187
  8. 8

    Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.

    Bozkurt B, Coats AJS, Tsutsui H, et al.

    European journal of heart failure 2021; (23(3)):352-380 doi:10.1002/ejhf.2115.

    PMID: 33605000

This guide is for informational purposes only and does not constitute medical advice or replace your individualized discharge instructions. Do not stop or change heart medicines without your prescribing care team, and seek emergency help for new severe symptoms.

Get notified when new evidence is published on myocardial infarction.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.